Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Common Equity (2016 - 2025)

Historic Common Equity for Argan (AGX) over the last 17 years, with Q4 2025 value amounting to $419.7 million.

  • Argan's Common Equity rose 2768.63% to $419.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $419.7 million, marking a year-over-year increase of 2768.63%. This contributed to the annual value of $351.9 million for FY2025, which is 2093.84% up from last year.
  • According to the latest figures from Q4 2025, Argan's Common Equity is $419.7 million, which was up 2768.63% from $393.2 million recorded in Q3 2025.
  • Argan's 5-year Common Equity high stood at $419.7 million for Q4 2025, and its period low was $271.7 million during Q4 2022.
  • Its 5-year average for Common Equity is $319.9 million, with a median of $315.2 million in 2021.
  • In the last 5 years, Argan's Common Equity tumbled by 2231.45% in 2022 and then surged by 2768.63% in 2025.
  • Argan's Common Equity (Quarter) stood at $349.8 million in 2021, then decreased by 22.31% to $271.7 million in 2022, then increased by 4.82% to $284.8 million in 2023, then rose by 15.4% to $328.7 million in 2024, then rose by 27.69% to $419.7 million in 2025.
  • Its last three reported values are $419.7 million in Q4 2025, $393.2 million for Q3 2025, and $363.9 million during Q2 2025.